Diagnostic criteria for polymyositis and dermatomyositis
Frederick W. Miller(National Institutes of Health), Chester V. Oddis(University of Pittsburgh), Lisa G. Rider(United States Food and Drug Administration), Paul H. Plötz(National Institutes of Health), David Isenberg(Regenerative Medicine Institute)
Cited by 66
Related Papers
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Autoimmune-Associated Congenital Heart Block: Demographics, Mortality, Morbidity and Recurrence Rates Obtained From a National Neonatal Lupus Registry
|Journal of the American College of Cardiology|1998|748
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
|Proceedings of the National Academy of Sciences|2007|598